AI assistant
Verisk Analytics, Inc. — Director's Dealing 2020
Feb 20, 2020
30087_dirs_2020-02-20_15570fdb-0f66-40c2-a03f-d5056b0e9c56.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Verisk Analytics, Inc. (VRSK)
CIK: 0001442145
Period of Report: 2020-02-12
Reporting Person: Daffan Nicholas (Chief Information Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 19677 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $48.84 | 2022-12-14 | Common Stock (3204) | Direct | |
| Stock Option | $61.14 | 2023-04-01 | Common Stock (9453) | Direct | |
| Stock Option | $59.74 | 2024-04-01 | Common Stock (13679) | Direct | |
| Stock Option | $71.53 | 2025-04-01 | Common Stock (11004) | Direct | |
| Stock Option | $80.19 | 2026-04-01 | Common Stock (13038) | Direct | |
| Stock Option | $81.14 | 2027-04-01 | Common Stock (14516) | Direct | |
| Stock Option | $104.00 | 2028-04-01 | Common Stock (16496) | Direct | |
| Stock Option | $107.64 | 2028-07-01 | Common Stock (11295) | Direct | |
| Stock Option | $134.24 | 2029-04-01 | Common Stock (15619) | Direct | |
| Stock Option | $158.65 | 2030-01-15 | Common Stock (15541) | Direct |
Footnotes
F1: This amount includes 11,570 restricted shares of Common Stock that were granted under the Issuer's 2013 Equity Incentive Plan. Subject to the terms of the Issuer's 2013 Equity Incentive Plan and the applicable award agreements thereunder, these restricted shares vest in four equal installments on the first, second, third and fourth anniversaries of their respective grant dates.
F2: Stock Options outstanding under the Issuer's 2009 Equity Incentive Plan.
F3: Immediately.
F4: Stock Options outstanding under the Issuer's 2013 Equity Incentive Plan.
F5: 9,778 shares of Common Stock underlying this Stock Option are immediately, exercisable. The remaining 3,260 shares will become exercisable on 4/1/2020.
F6: 7,258 shares of Common Stock underlying this Stock Option are immediately exercisable. The remaining 7,258 shares will become exercisable as follows: 3,629 shares on 4/1/2020, and 3,629 shares on 4/1/2021.
F7: 4,124 shares of Common Stock underlying this Stock Option are immediately exercisable. The remaining 12,372 shares will become exercisable as follows: 4,124 shares on 4/1/2020, 4,124 shares on 4/1/2021, and 4,124 shares on 4/1/2022.
F8: 2,823 shares of Common Stock underlying this Stock Option are immediately exercisable. The remaining 8,472 shares will become exercisable as follows: 2,824 shares on 7/1/2020, 2,824 shares on 7/1/2021, and 2,824 shares on 7/1/2022.
F9: The 15,619 shares of Common Stock underlying this Stock Option will become exercisable as follows: 3,904 shares on 4/1/2020, 3,905 shares on 4/1/2021, 3,905 shares on 4/1/2022, and 3,905 shares on 4/1/2023.
F10: The 15,541 shares of Common Stock underlying this Stock Option will become exercisable as follows: 3,885 shares on 1/15/2021, 3,885 shares on 1/15/2022, 3,885 shares on 1/15/2023, and 3,885 shares on 1/15/2024.